<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>RSS for Urinary 11-dehydro thromboxane B 2 levels in type 2 diabetic patients before and during aspirin intake</title><link>http://academic.research.microsoft.com/Rss.aspx?cata=9&amp;id=49298337</link><description>Search RSS feed for Microsoft Academic Search</description><generator>MSRA Libra RSS Burner</generator><copyright>(c)2008 Microsoft Corpration, All right reserved.</copyright><pubDate>Tue, 21 May 2013 16:28:32 GMT</pubDate><lastBuildDate>Tue, 21 May 2013 16:28:32 GMT</lastBuildDate><category /><item><title>Urinary 11-dehydro thromboxane B 2 levels in type 2 diabetic patients before and during aspirin intake</title><link>http://academic.research.microsoft.com/Publication/49298337</link><pubDate>Tue, 21 May 2013 09:28:32 GMT</pubDate><guid isPermaLink="false">492983370</guid><description><![CDATA[<div><a href="http://academic.research.microsoft.com/Author/44479862">Lillian Harboe Gonçalves</a>, <a href="http://academic.research.microsoft.com/Author/21522791">Luci Maria Sant'Ana Dusse</a>, <a href="http://academic.research.microsoft.com/Author/47412136">Ana Paula Fernandes</a>, <a href="http://academic.research.microsoft.com/Author/5477617">Karina Braga Gomes</a>, <a href="http://academic.research.microsoft.com/Author/44862239">Mirelle Oliveira Sóter</a>, <a href="http://academic.research.microsoft.com/Author/50160311">Michelle Teodoro Alves</a>, <a href="http://academic.research.microsoft.com/Author/44803613">Kathryna Fontana Rodrigues</a>, <a href="http://academic.research.microsoft.com/Author/52296583">Fernanda Rocha Freitas</a>, <a href="http://academic.research.microsoft.com/Author/52592826">Flavia Komatsuzaki</a>, <a href="http://academic.research.microsoft.com/Author/55726201">Marinez Oliveira Sousa</a>, <a href="http://academic.research.microsoft.com/Author/43079242">Adriana Aparecida Bosco</a>, <a href="http://academic.research.microsoft.com/Author/44609203">Gérson Antônio Pianett</a>, <a href="http://academic.research.microsoft.com/Author/13373126">Maria das Graças Carvalho</a>:
            
            <span style="margin-left:20px" /><span style="margin-left:20px"><a href="http://www.sciencedirect.com/science/article/pii/S0009898111002002">view publication</a></span></div><div>BackgroundDiabetic patients commonly present an increased risk for cardiovascular events, for which aspirin is the most frequently used medication for primary prevention. Urinary 11-dehydro thromboxane (11-dhTXB2) concentrations assess the effect of aspirin on platelets and identify patients who are at risk of cardiovascular events. The present study investigated whether or not type 2 diabetic patients who took a daily dose of 100mg of aspirin had a significant reduction in urinary 11-dhTXB2 concentrations and whether these results were associated with clinical and laboratory variables.</div><div></div><div>Journal: <a href="http://academic.research.microsoft.com/Journal/2873">Clinica Chimica Acta - CLIN CHIM ACTA</a>, vol. 412, no. 15, pp. 1366-1370, 2011</div><div />]]></description></item></channel></rss>